CVSACovista Inc.

$129.41-8.0% 1Y

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap vs its sector.

2 good, 1 neutral
What the price assumes~−3% a year

Priced for a decline (~−3% a year). The price demands less than its three-year revenue growth of 10% a year, expectations look modest.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 18.4 vs a 19.3 median over 31 quarters (−4% vs median).

Vs sector (EV/EBIT)11.7×

Sector median 16.6× across 78 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market
FCF yieldbetter than 83% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CVSA's price assumes

Covista Inc. trades at 18.4× earnings against 18.1× for the median Education & Training Services name, more expensive than its own group.

18.4

Trailing P/E · Education & Training Services median 18.1 · 1.01× the median: the market pays up for this one

Price / sales
2.16

Price / sales · today's price, trailing year to Jun 30, 2026

Free cash flow yield
9.3%

Free cash flow yield · Education & Training Services median 9.7%

Growth the price implies
−2.6%

Growth the price implies · The price pays for −2.6% free cash flow growth a year for a decade; the business has delivered +35% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
2.92
EV / EBITtoday's price, trailing year to Jun 30, 2026
11.7
EV / salestoday's price, trailing year to Jun 30, 2026
2.29
Consumer Defensive median P/E142 names
20.2
Education & Training Services median P/E18 names
18.1
Free cash flow, trailing twelve months
$393M
Market capitalisation
$4.23B
3-year revenue growth
+10%
3-year free cash flow growth
+35%
What the market has paid for these earnings: 31 quarters of its own multiple × $7.03 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$118.76
Its own P/E history, median$135.33
Its own P/E history, upper quartile$165.92
52-week range$89.36 – $154.45
Today$129.41

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.